184 related articles for article (PubMed ID: 16984263)
1. Expression of chitinase-like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice.
HogenEsch H; Dunham A; Seymour R; Renninger M; Sundberg JP
Exp Dermatol; 2006 Oct; 15(10):808-14. PubMed ID: 16984263
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm).
Gijbels MJ; Zurcher C; Kraal G; Elliott GR; HogenEsch H; Schijff G; Savelkoul HF; Bruijnzeel PL
Am J Pathol; 1996 Mar; 148(3):941-50. PubMed ID: 8774148
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of chemokines in the skin of chronic proliferative dermatitis mutant mice.
Renninger ML; Seymour R; Lillard JW; Sundberg JP; HogenEsch H
Exp Dermatol; 2005 Dec; 14(12):906-13. PubMed ID: 16274458
[TBL] [Abstract][Full Text] [Related]
4. Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice.
HogenEsch H; Janke S; Boggess D; Sundberg JP
J Immunol; 1999 Apr; 162(7):3890-6. PubMed ID: 10201907
[TBL] [Abstract][Full Text] [Related]
5. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex.
Tamiya H; Terao M; Takiuchi T; Nakahara M; Sasaki Y; Katayama I; Yoshikawa H; Iwai K
J Immunol; 2014 Apr; 192(8):3793-804. PubMed ID: 24634492
[TBL] [Abstract][Full Text] [Related]
6. Markers of macrophage differentiation in experimental silicosis.
Misson P; van den Brûle S; Barbarin V; Lison D; Huaux F
J Leukoc Biol; 2004 Nov; 76(5):926-32. PubMed ID: 15292275
[TBL] [Abstract][Full Text] [Related]
7. D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells.
Mori T; Kabashima K; Fukamachi S; Kuroda E; Sakabe J; Kobayashi M; Nakajima S; Nakano K; Tanaka Y; Matsushita S; Nakamura M; Tokura Y
J Dermatol Sci; 2013 Jul; 71(1):37-44. PubMed ID: 23639699
[TBL] [Abstract][Full Text] [Related]
8. The presence of tryptase-positive and bikunin-negative mast cells in psoriatic skin lesions.
Ashenagar MS; Sugihara K; Maeda A; Isogai R; Takahashi M; Aisu K; Horiuchi A; Aragane Y; Kawada A; Tezuka T
Arch Dermatol Res; 2007 Feb; 298(9):421-6. PubMed ID: 17146627
[TBL] [Abstract][Full Text] [Related]
9. Nephropathy in Hypertensive Animals Is Linked to M2 Macrophages and Increased Expression of the YM1/Chi3l3 Protein.
Cavalcante PAM; Alenina N; Budu A; Freitas-Lima LC; Alves-Silva T; Agudelo JSH; Qadri F; Camara NOS; Bader M; Araújo RC
Mediators Inflamm; 2019; 2019():9086758. PubMed ID: 31360120
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, in NC/Nga mice.
Kang JS; Yoon WK; Youm JK; Jeong SK; Park BD; Han MH; Lee H; Moon EY; Han SB; Lee CW; Lee K; Park SK; Yang KH; Kim HM
Exp Dermatol; 2008 Nov; 17(11):958-64. PubMed ID: 18721197
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin inhibits intercellular adhesion molecule-1 expression and reduces mast cell numbers in the asebia mouse model of chronic skin inflammation.
Oran A; Marshall JS; Kondo S; Paglia D; McKenzie RC
Br J Dermatol; 1997 Apr; 136(4):519-26. PubMed ID: 9155951
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.
Honda T; Matsuoka T; Ueta M; Kabashima K; Miyachi Y; Narumiya S
J Allergy Clin Immunol; 2009 Oct; 124(4):809-18.e2. PubMed ID: 19541354
[TBL] [Abstract][Full Text] [Related]
13. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a quantitative PCR system for discriminating chitinase-like proteins: catalytically inactive breast regression protein-39 and Ym1 are constitutive genes in mouse lung.
Ohno M; Kida Y; Sakaguchi M; Sugahara Y; Oyama F
BMC Mol Biol; 2014 Oct; 15():23. PubMed ID: 25294623
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12.
HogenEsch H; Torregrosa SE; Boggess D; Sundberg BA; Carroll J; Sundberg JP
Eur J Immunol; 2001 Mar; 31(3):734-42. PubMed ID: 11241277
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin.
Katagiri K; Arakawa S; Hatano Y; Fujiwara S
Arch Dermatol Res; 2008 Nov; 300(10):583-93. PubMed ID: 18528699
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa.
Gijbels MJ; HogenEsch H; Bruijnzeel PL; Elliott GR; Zurcher C
J Invest Dermatol; 1995 Dec; 105(6):769-73. PubMed ID: 7490470
[TBL] [Abstract][Full Text] [Related]
18. Changes in keratin and filaggrin expression in the skin of chronic proliferative dermatitis (cpdm) mutant mice.
HogenEsch H; Boggess D; Sundberg JP
Pathobiology; 1999; 67(1):45-50. PubMed ID: 9873228
[TBL] [Abstract][Full Text] [Related]
19. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
Terakawa M; Fujieda Y; Tomimori Y; Muto T; Tanaka T; Maruoka H; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
Eur J Pharmacol; 2008 Dec; 601(1-3):186-91. PubMed ID: 18996112
[TBL] [Abstract][Full Text] [Related]
20. Induction of Ym1/2 in mouse bone marrow-derived mast cells by IL-4 and identification of Ym1/2 in connective tissue type-like mast cells derived from bone marrow cells cultured with IL-4 and stem cell factor.
Lee E; Yook J; Haa K; Chang HW
Immunol Cell Biol; 2005 Oct; 83(5):468-74. PubMed ID: 16174095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
